Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Enovis (ENOV) Net Income Growth (3y) (2013 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income Growth (3y) (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	-6.51%
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	7.96%
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	-2.19%
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	62.29%
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	343.24%
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	60.12%
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	2.38%
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	-
10	Enovis	1.25 Bn	1.22 Bn	365.49 Mn	50.00%

Historic Data

Download Data 🔒

Date	Value
Apr 3, 2026	50.00%
Dec 31, 2025	-28.09%
Oct 3, 2025	57.66%
Jul 4, 2025	87.13%
Apr 4, 2025	-26.04%
Dec 31, 2024	-68.91%
Sep 27, 2024	-61.86%
Jun 28, 2024	-26.01%
Dec 31, 2023	26.03%
Sep 29, 2023	102.39%
Jun 30, 2023	43.87%
Mar 31, 2023	54.72%
Dec 31, 2022	32.52%
Sep 30, 2022	-27.21%
Jul 1, 2022	54.67%
Apr 1, 2022	59.44%
Dec 31, 2021	6.18%
Oct 1, 2021	29.67%
Jul 2, 2021	140.12%
Apr 2, 2021	84.59%
Dec 31, 2020	-26.76%
Oct 2, 2020	-48.41%
Jul 3, 2020	-31.91%
Apr 3, 2020	-45.57%
Dec 31, 2019	-421.37%
Sep 27, 2019	45.51%
Jun 28, 2019	-1,750.36%
Mar 29, 2019	-222.80%
Dec 31, 2018	83.01%
Sep 28, 2018	-7.65%
Jun 29, 2018	-28.12%
Mar 30, 2018	-47.20%
Dec 31, 2017	33.09%
Sep 29, 2017	-70.52%
Jun 30, 2017	-56.25%
Mar 31, 2017	-61.63%
Dec 31, 2016	-26.16%
Sep 30, 2016	-28.61%
Jul 1, 2016	-26.02%
Apr 1, 2016	-26.50%
Dec 31, 2015	-28.35%
Sep 25, 2015	17.54%
Jun 26, 2015	46.70%
Mar 27, 2015	36.80%
Dec 31, 2014	94.30%
Sep 26, 2014	180.35%
Jun 27, 2014	167.26%
Mar 28, 2014	103.00%
Dec 31, 2013	72.23%
Sep 27, 2013	123.67%
Jun 28, 2013	218.09%